Corteva Raises FY Outlook After Strong 1H, Operating EPS Up 14%
CTVA sits 35% above its 52-week low of $60.535.
Summary
Corteva posted strong first-half results with operating EPS of $3.80, up 14% year-over-year, driven by demand for next-gen seed technologies and new crop protection products. The company raised full-year 2026 guidance, now expecting operating EBITDA of $4.1-$4.3 billion and operating EPS of $3.60-$3.80. The planned separation of Vylor remains on track for October 1, with key milestones including board appointments and capital structure reviews already completed. This follows a series of positive developments, including a strong Q1 beat and restructuring updates, reinforcing the company's momentum heading into the spin-off.
At the time of this announcement, CTVA was trading at $82.01 on NYSE in the Life Sciences sector, with a market capitalization of approximately $59.8B. The 52-week trading range was $60.54 to $90.97. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.